Literature DB >> 9704905

Temporal variation in hepatotoxicity and metabolism of acetaminophen in mice.

Y C Kim1, S J Lee.   

Abstract

Temporal variation in metabolism and hepatotoxicity of acetaminophen (APAP) was examined using male ICR mice. Animals were injected with a single dose of APAP (400 mg/kg, i.p.) at 08:00, 14:00 or 20:00 h. APAP at this dose was markedly hepatotoxic to mice when administered at 20:00 h as determined by increases in serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) activities, and by decreases in hepatic glucose-6-phosphatase (G-6-Pase) activity. However, mice appeared to be entirely insensitive to an identical dose of APAP given either at 08:00 or 14:00 h. Hepatic glutathione (GSH) level was significantly higher at 08:00, but no difference in GSH levels between 14:00 and 20:00 h was observed in normal mice. APAP and its metabolites in blood were monitored using HPLC for 3 h following the treatment. There were no significant differences in the plasma concentrations of APAP, APAP-glucuronide, APAP-sulfate, or APAP-mercapturate among the mice treated with this drug at 08:00, 14:00 or 20:00 h. However, the APAP-cysteine and APAP-GSH levels measured at 1 h following the APAP treatment were significantly lower in mice treated with this analgesic either at 14:00 or 20:00 h. In vitro hepatic microsomal p-nitrophenol hydroxylase activities were not different between 08:00, 14:00 and 20:00 h. But ethoxyresorufin O-deethylase and aminopyrine N-demethylase activities measured at 14:00 h were significantly lower than those of 08:00 or 20:00 h. Thus, the greater hepatotoxicity of APAP administered at 20:00 h appears to be related to the marked decrease in hepatic GSH at this time period, whereas the simultaneous reduction in APAP activation may be responsible for the lack of hepatotoxicity in mice treated with this analgesic at 14:00 h. These results suggest that the temporal variation in hepatotoxicity and metabolism of APAP is determined by interactions of multiple factors including the hepatic GSH level and drug metabolizing activities.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9704905     DOI: 10.1016/s0300-483x(98)00046-8

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  16 in total

1.  P2X7 receptor-mediated purinergic signaling promotes liver injury in acetaminophen hepatotoxicity in mice.

Authors:  Rafaz Hoque; Muhammed Adnan Sohail; Steven Salhanick; Ahsan F Malik; Ayaz Ghani; Simon C Robson; Wajahat Z Mehal
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-01       Impact factor: 4.052

2.  The hepatic circadian clock modulates xenobiotic metabolism in mice.

Authors:  Jason P DeBruyne; David R Weaver; Robert Dallmann
Journal:  J Biol Rhythms       Date:  2014-08       Impact factor: 3.182

3.  Influence of the Time of Intravenous Administration of Paracetamol on its Pharmacokinetics and Ocular Disposition in Rabbits.

Authors:  Agnieszka Karbownik; Agnieszka Bienert; Włodzimierz Płotek; Tomasz Grabowski; Magdalena Cerbin-Koczorowska; Anna Wolc; Edmund Grześkowiak
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-06       Impact factor: 2.441

4.  Mice deficient in Cu,Zn-superoxide dismutase are resistant to acetaminophen toxicity.

Authors:  Xin Gen Lei; Jian-Hong Zhu; James P McClung; Manuel Aregullin; Carol A Roneker
Journal:  Biochem J       Date:  2006-11-01       Impact factor: 3.857

5.  Gut microbiota mediates diurnal variation of acetaminophen induced acute liver injury in mice.

Authors:  Shenhai Gong; Tian Lan; Liyan Zeng; Haihua Luo; Xiaoyu Yang; Na Li; Xiaojiao Chen; Zhanguo Liu; Rui Li; Sanda Win; Shuwen Liu; Hongwei Zhou; Bernd Schnabl; Yong Jiang; Neil Kaplowitz; Peng Chen
Journal:  J Hepatol       Date:  2018-03-08       Impact factor: 25.083

6.  Hepatocyte circadian clock controls acetaminophen bioactivation through NADPH-cytochrome P450 oxidoreductase.

Authors:  Brian P Johnson; Jacqueline A Walisser; Yan Liu; Anna L Shen; Erin L McDearmon; Susan M Moran; Brian E McIntosh; Aaron L Vollrath; Andrew C Schook; Joseph S Takahashi; Christopher A Bradfield
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-15       Impact factor: 11.205

7.  A NO-releasing derivative of acetaminophen spares the liver by acting at several checkpoints in the Fas pathway.

Authors:  Stefano Fiorucci; Elisabetta Antonelli; Andrea Mencarelli; Barbara Palazzetti; Lorena Alvarez-Miller; Marcelo Muscara; Piero del Soldato; Laura Sanpaolo; John L Wallace; Antonio Morelli
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

8.  Effects of Photoperiod on Acetaminophen-Induced Hepatotoxicity in Mice.

Authors:  Jihong Lu; Hu Wang; Rumeng Zhang; Zhikang Wan; Hang Gao; Jie Cai; Yujia Cheng; Dong Pu; Tengfei Lin; Chenyu Fan; Ying Sun
Journal:  Dig Dis Sci       Date:  2019-08-02       Impact factor: 3.199

9.  Blood gene expression markers to detect and distinguish target organ toxicity.

Authors:  Christina Umbright; Rajendran Sellamuthu; Shengqiao Li; Michael Kashon; Michael Luster; Pius Joseph
Journal:  Mol Cell Biochem       Date:  2009-09-26       Impact factor: 3.396

10.  Circadian expression profiles of drug-processing genes and transcription factors in mouse liver.

Authors:  Yu-Kun Jennifer Zhang; Ronnie L Yeager; Curtis D Klaassen
Journal:  Drug Metab Dispos       Date:  2008-10-06       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.